Matinas BioPharma (MTNB) Reports In-Line Q4 EPS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
| (NYSE: MTNB) | Delayed: 1.19 +0.05 (4.39%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.14 | 52 Week High | $2.01 | |||
| Open | $1.17 | 52 Week Low | $0.41 | |||
| Day High | $1.20 | P/E | N/A | |||
| Day Low | $1.07 | EPS | $0.00 | |||
| Volume | 17,594 | |||||
